Of the people, most of the people, who were is central to his political rise. Tonight at 8 00 eastern on cspans q a. Commissioner scott along with Industry Experts discuss Prescription Drug access and costs as well as balancing industry competition with public safety. This is two hours. [inaudible conversations] quite so it like to thank our sor i would like to thank our sponsor. This morning, we are focused on the cost of medicine. Are rising faster than Overall Health care spending. The concern the warehouse is expected to unveil the executive order even as we wait for direction with a how can the entity help manage costs and keep it successful for all americans . Are marketbased solutions being explored . We will hear from government leaders and Patient Advocates as they explore a landscape where patients can get the medicine they need at and up at a price they can afford. If you notes of housekeeping. In addition to those of you here in the studio, we are Live Streaming and we ask
Looked at his agents role in improving the process. Held by the hill, this is two hours. Welcome to this mornings briefing, Prescription Drug system, ensuring access. Id like to thank our sponsor, the coalition, for affordable Prescription Drugs for making this possible. This is the first in a series of two events sponsored by the coalition to explore some of the most pressing issues facing the u. S. Health care industry. This morning we are focused on the cost of medicine. In the United States, expenditures on Prescription Drugs are rising faster than Overall Health care spending. Reacting to the concern over rising prices, the white house is expected to unveil an executive order examining ways to reign in drug costs. Even as we wait for direction from the government, how can every entity within the Prescription Drug Delivery System help manage costs and keep medicines accessible for all americans, and what innovative marketbased solutions are being ex morning drive oh plord and what
Looked at his agents role in improving the process. Held by the hill, this is two hours. Welcome to this mornings briefing, Prescription Drug system, ensuring access. Id like to thank our sponsor, the coalition, for affordable Prescription Drugs for making this possible. This is the first in a series of two events sponsored by the coalition to explore some of the most pressing issues facing the u. S. Health care industry. This morning we are focused on the cost of medicine. In the United States, expenditures on Prescription Drugs are rising faster than Overall Health care spending. Reacting to the concern over rising prices, the white house is expected to unveil an executive order examining ways to reign in drug costs. Even as we wait for direction from the government, how can every entity within the Prescription Drug Delivery System help manage costs and keep medicines accessible for all americans, and what innovative marketbased solutions are being ex morning drive oh plord and what
[inaudible conversations] [inaudible conversations] to explore some of the most pressing issues of the health care industry. Were focused all of the cost of medicine. And with the over rising prices. To examine the ways to reagan the drug caused. How can every entity keep medicines accessible for all americans . And to be explored with a hearing from government leaders and Patient Advocates as they explore at a price they can afford. And in addition to those here were also Live Streaming please keep your phone on silent but we encourage you to join the conversation and we will be taking questions and to please give the survey to a staff member of the way out. Good morning banks for this important conversation of today we appreciate that distinguished speakers and panelists we go this is a slow time in washington and for health care and there is nothing else to be focused on so thanks for being here but and with the rising drug prices in the impact of american in families and taxpayers
Medicare plans scored better than both commercial and Medicaid plans on individual quality measures included in the National Committee for Quality Assurance's 2022 Health Plans Ratings.